411 related articles for article (PubMed ID: 30690249)
1. Identification of novel serum biomarker for the detection of acute myeloid leukemia based on liquid chromatography-mass spectrometry.
Wang D; Tan G; Wang H; Chen P; Hao J; Wang Y
J Pharm Biomed Anal; 2019 Mar; 166():357-363. PubMed ID: 30690249
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics analysis identifies lysine and taurine as candidate prognostic biomarkers for AML-M2 patients.
Zhou X; Zheng M; Wang Q; Aa J; Cao B; Li J
Int J Hematol; 2020 Jun; 111(6):761-770. PubMed ID: 32056080
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
Shang X; Zhong X; Tian X
Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
[TBL] [Abstract][Full Text] [Related]
4. Serum metabolic profiling study of lung cancer using ultra high performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Li Y; Song X; Zhao X; Zou L; Xu G
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():147-53. PubMed ID: 24856296
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer detection using targeted plasma metabolomics.
Jasbi P; Wang D; Cheng SL; Fei Q; Cui JY; Liu L; Wei Y; Raftery D; Gu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():26-37. PubMed ID: 30562627
[TBL] [Abstract][Full Text] [Related]
6. Rapid diagnosis and prognosis of de novo acute myeloid leukemia by serum metabonomic analysis.
Wang Y; Zhang L; Chen WL; Wang JH; Li N; Li JM; Mi JQ; Zhang WN; Li Y; Wu SF; Jin J; Wang YG; Huang H; Chen Z; Chen SJ; Tang H
J Proteome Res; 2013 Oct; 12(10):4393-401. PubMed ID: 23998518
[TBL] [Abstract][Full Text] [Related]
7. Dynamic urinary metabolomics analysis based on UHPLC-Q-TOF/MS to investigate the potential biomarkers of blood stasis syndrome and the effects of Danggui Sini decoction.
Huang H; Wu J; Lu R; Liu X; Chin B; Zhu H; Yin C; Cheng B; Wu Z; Chen X; Liang Y; Song H; Zheng H; Guo H; Su Z
J Pharm Biomed Anal; 2020 Feb; 179():112986. PubMed ID: 31787459
[TBL] [Abstract][Full Text] [Related]
8. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
9. Integrated biomarker for type 2 diabetes mellitus and impaired fasting glucose based on metabolomics analysis using ultra-high performance liquid chromatography quadrupole-Orbitrap high-resolution accurate mass spectrometry.
Long J; Liu L; Jia Q; Yang Z; Sun Z; Yan C; Yan D
Rapid Commun Mass Spectrom; 2020 Jun; 34(12):e8779. PubMed ID: 32159245
[TBL] [Abstract][Full Text] [Related]
10. Serum metabolomics of laryngeal cancer based on liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
Zhang X; Hou H; Chen H; Liu Y; Wang A; Hu Q
Biomed Chromatogr; 2018 May; 32(5):e4181. PubMed ID: 29272549
[TBL] [Abstract][Full Text] [Related]
11. Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics method.
Zhou Y; Song R; Ma C; Zhou L; Liu X; Yin P; Zhang Z; Sun Y; Xu C; Lu X; Xu G
Oncotarget; 2017 Mar; 8(13):20719-20728. PubMed ID: 28157703
[TBL] [Abstract][Full Text] [Related]
12. Three serum metabolite signatures for diagnosing low-grade and high-grade bladder cancer.
Tan G; Wang H; Yuan J; Qin W; Dong X; Wu H; Meng P
Sci Rep; 2017 Apr; 7():46176. PubMed ID: 28382976
[TBL] [Abstract][Full Text] [Related]
13. Discovery and Validation of Potential Serum Biomarkers for Pediatric Patients with Congenital Heart Diseases by Metabolomics.
Yu M; Sun S; Yu J; Du F; Zhang S; Yang W; Xiao J; Xie B
J Proteome Res; 2018 Oct; 17(10):3517-3525. PubMed ID: 30207476
[TBL] [Abstract][Full Text] [Related]
14. Identification of Potential Biomarkers and Metabolic Profiling of Serum in Ovarian Cancer Patients Using UPLC/Q-TOF MS.
Yang W; Mu T; Jiang J; Sun Q; Hou X; Sun Y; Zhong L; Wang C; Sun C
Cell Physiol Biochem; 2018; 51(3):1134-1148. PubMed ID: 30476914
[TBL] [Abstract][Full Text] [Related]
15. [Preliminarily screening of serum characteristic markers in acute myeloid leukemia and clinical significance].
He AL; Bai J; Huang C; Zhang WG; Yang J; Wang JL; Meng X; Tian W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1132-7. PubMed ID: 21129246
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA LINC00899 as a novel serum biomarker for diagnosis and prognosis prediction of acute myeloid leukemia.
Wang Y; Li Y; Song HQ; Sun GW
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7364-7370. PubMed ID: 30468482
[TBL] [Abstract][Full Text] [Related]
17. Study of the metabolomics characteristics of patients with metabolic syndrome based on liquid chromatography quadrupole time-of-flight mass spectrometry.
Wu N; Wang W; Yi M; Cheng S; Wang D
Ann Endocrinol (Paris); 2018 Feb; 79(1):37-44. PubMed ID: 29246383
[TBL] [Abstract][Full Text] [Related]
18. UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer.
Wang X; Guan X; Tong Y; Liang Y; Huang Z; Wen M; Luo J; Chen H; Yang S; She Z; Wei Z; Zhou Y; Qi Y; Zhu P; Nong Y; Zhang Q
BMC Cancer; 2024 May; 24(1):644. PubMed ID: 38802800
[TBL] [Abstract][Full Text] [Related]
19. A serum lipidomic strategy revealed potential lipid biomarkers for early-stage cervical cancer.
Cheng F; Wen Z; Feng X; Wang X; Chen Y
Life Sci; 2020 Nov; 260():118489. PubMed ID: 32976882
[TBL] [Abstract][Full Text] [Related]
20. Urinary metabolomics for discovering metabolic biomarkers of laryngeal cancer using UPLC-QTOF/MS.
Chen J; Hou H; Chen H; Luo Y; Zhang L; Zhang Y; Liu H; Zhang F; Liu Y; Wang A; Hu Q
J Pharm Biomed Anal; 2019 Apr; 167():83-89. PubMed ID: 30759408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]